Medical news
-
Update on Ferring recall of desmopressin nasal sprays
Ferring Pharmaceuticals has issued an update on the global recall in July and August 2020 of its desmopressin nasal sprays, including the 1.5 mg/ml desmopressin...
-
ASH ISTH NHF WFH VWD Guidelines Published
On January 7, 2021, the culmination of a multiyear international collaboration was published in Blood Advances: ASH ISTH NHF WFH Guidelines on the Diagnosis of...
-
COVID-19 vaccination guidance for people with bleeding disorders
Guidance from the World Federation of Hemophilia (WFH), European Association for Haemophilia and Allied Disorders (EAHAD), European Haemophilia Consortium (EHC), and U.S. National Hemophilia Foundation...
-
Sanofi to resume dosing in fitusiran clinical studies with protocol amendments
Sanofi has announced plans to resume dosing in its ongoing fitusiran clinical studies, lifting the voluntary global hold that was initiated on October 30 to...
-
CSL Behring to discontinue plasma-derived therapy for hemophilia B
CSL Behring has announced the discontinuation of its plasma-derived factor IX concentrate Mononine®, used in the treatment and prevention of bleeding in hemophilia B, citing...
